Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Nov 15, 2023 8:04am
167 Views
Post# 35736285

Just to bring into the light the much larger global view

Just to bring into the light the much larger global viewof cannabinoid pharmaceuticals, the big picture now involving countries such as Canada, U.S., Brazil, China as quick and dirty examples reflecting a global perspective relative to Medipharm Labs and their focus as a pharmaceutical company specializing in cannabinoids as well as advanced derivatives for the pharmaceutical industry.  

I would not at all be surprised for Uncle Sam to put sanctions upon another country and a company within the country not to export to China, be it ASML of the Netherlands and their advanced lithography equipment capable of going down to the 4 nm node in chip fabrication or sanctions on Medipharm Labs not to export their advanced cannabinoid derivatives to China because Uncle Sam thinks like a dictator and thinks they can dictate economic policy to other countries and negatively affect other companies by restricting thier endeavors within capitalism.   When you think of Janus with 2 faces, you now see the 2 faces of Uncle Sam.  
<< Previous
Bullboard Posts
Next >>